Transcript
Page 1: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

Intermountain-led CMS Hospital Engagement Network

Adverse Drug Event PreventionSeptember 23, 2014

Affinity Call

Jason Trahan, Pharm.D.Director of Pharmacy – Medication Safety,

Baylor Scott & White

Lucy Savitz, Ph.D., M.B.A.HEN Director

Page 2: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

Outline for Discussion

• Review of the HEN ADE work • “Just-one-thing” Recommendations• High performers• Pharmacy Patient Safety at Baylor Scott &

White • Q & A/ Discussion

Page 3: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

Overall Progress Through Q1 2014

Page 4: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

Intermountain HEN 2012-Q1 2014 ADE w/ Harm

Page 5: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

Intermountain HEN 2012-Q1 2014 ADE w/ Harm

Page 6: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

Intermountain HEN 2012-Q1 2014 ADE per 1000 Patient-Days

Page 7: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

Intermountain HEN 2012-Q1 2014 ADE per 1000 Patient-Days

Page 8: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

Intermountain HEN 2012-Q1 2014 PSI 12 Post Operative PE or DVT

Page 9: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

Intermountain HEN 2012-Q1 2014 PSI 12 Post Operative PE or DVT

Page 10: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

Intermountain HEN 2012-Q1 2014

• ADE Due to Opioids

• Controlled Postoperative Serum Glucose

• Excessive Anticoagulation with Warfarin

– Low Reporting

Page 11: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

Just One Thing MatrixRecommendations

Getting Started Working Harder Ahead of the Curve

Identify accountable teams to review all ADEs and work on performance improvement.(moderate level of evidence)

Build in automated medication administration alerts and processes, i.e., bar coding.(low level of evidence)

Automate ADE triggers and implement into pharmacy work flow with patient specific alerts.

Page 12: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

High Performing Hospital Highlight…ADE w/ Harm

Most Improvement

SANPETE VALLEY HOSPITAL - CAHSUTTER MATERNITY & SURGERY CENTER OF SANTA CRUZ

DENVER HEALTH MEDICAL CENTER

SOCORRO GENERAL HOSPITAL

BEAR RIVER VALLEY HOSPITAL

EDEN MEDICAL CENTER

RIVERTON HOSPITAL

DIXIE REGIONAL MEDICAL CENTER

VALLEY VIEW MEDICAL CENTER

SUTTER ROSEVILLE MEDICAL CENTER

Lowest Rates

MILLS PENINSULA HEALTH SERVICESSUTTER MATERNITY & SURGERY CENTER OF SANTA CRUZ

LOS BANOS MEMORIAL HOSPITAL

PARK CITY MEDICAL CENTER

MENLO PARK SURGICAL HOSPITAL

LINCOLN COUNTY MEDICAL CENTER

SEVIER VALLEY MEDICAL CENTER

HEBER VALLEY MEDICAL CENTER

GARFIELD MEMORIAL HOSPITAL

UPPER CONNECTICUT VALLEY HOSPITAL

Page 13: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

High Performing Hospital Highlight…

Most Improvement

SANPETE VALLEY HOSPITAL - CAH

MENLO PARK SURGICAL HOSPITAL

DENVER HEALTH MEDICAL CENTER

SEVIER VALLEY MEDICAL CENTERSUTTER MATERNITY & SURGERY CENTER OF SANTA CRUZ

SUTTER SOLANO MEDICAL CENTER

BEAR RIVER VALLEY HOSPITAL

SUTTER COAST HOSPITAL

NOVATO COMMUNITY HOSPITAL

ALTA BATES SUMMIT MEDICAL CENTER

ADE per 1000 Patient-Days

Lowest Rates

MENLO PARK SURGICAL HOSPITAL

GARFIELD MEMORIAL HOSPITAL

SANPETE VALLEY HOSPITAL - CAH

DENVER HEALTH MEDICAL CENTER

MILLS PENINSULA HEALTH SERVICES

ALTA BATES SUMMIT MEDICAL CENTER

SEVIER VALLEY MEDICAL CENTER

LOS BANOS MEMORIAL HOSPITALSUTTER MATERNITY & SURGERY CENTER OF SANTA CRUZ

UTAH VALLEY REGIONAL MEDICAL CENTER

Page 14: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

High Performing Hospital Highlight…

Most Improvement

SUTTER LAKESIDE HOSPITAL

SUTTER SOLANO MEDICAL CENTER

SUTTER AUBURN FAITH HOSPITAL

VALLEY VIEW MEDICAL CENTER

LDS HOSPITAL

MCKAY DEE HOSPITAL CENTER

PROVIDENCE ST VINCENT MEDICAL CENTER

UTAH VALLEY REGIONAL MEDICAL CENTER

SUTTER MEDICAL CENTER OF SACRAMENTO

DENVER HEALTH MEDICAL CENTER

PSI 12 Post Operative PE or DVT

Lowest Rates

LOGAN REGIONAL HOSPITAL

SUTTER AUBURN FAITH HOSPITAL

SUTTER SOLANO MEDICAL CENTER

PARK CITY MEDICAL CENTER

SUTTER DAVIS HOSPITAL

HILLCREST BAPTIST MEDICAL CENTER

RIVERTON HOSPITAL

VALLEY VIEW MEDICAL CENTER

ESPANOLA HOSPITAL

SUTTER TRACY COMMUNITY HOSPITAL

Page 15: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

Pharmacy Patient Safety

September 23, 2014

Jason Trahan, Pharm.D.

Director of Pharmacy – Medication Safety

Page 16: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

16

Presentation Outline

• Focus on Pharmacist involvement in two of ten patient safety areas:

– Adverse Drug Events– Use of Data

» Vancomycin– Response to current literature

» Fentanyl Patches» Haloperidol Intravenous Use

– Injuries from Falls• Response to current literature

– Zolpidem

Page 17: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

17

Adverse Drug Events

• Changes evaluation from facility specific to enterprise-wide in 2013.

– Increased usefulness of data and trending

• Reported Quarterly at enterprise and facility meetings.

Page 18: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

18

Page 19: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

19

Vancomycin

• Facility specific practices collected / analyzed.• Pharmacy and Therapeutics Committee

approval to standardize infusion times to 10 mg/min.

• Implementation in Electronic Health Record, IV Pump Library, Order Sets, etc.

• Fully implemented first quarter 2014.

Page 20: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

20

Proactive Use of Data

• Facility specific practices collected / analyzed.• Pharmacy and Therapeutics Committee

approval to standardize infusion times to 10 mg/min.

• Implementation in Electronic Health Record, IV Pump Library, Order Sets, etc.

• Fully implemented first quarter 2014.

Page 21: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

21

Response to Current LiteratureFentanyl Patch Disposal

• FDA Alerts:– April 2012 (Accidental Exposure)– September 2013 (Patch Writing Color Change)

• Institute for Safe Medication Practices:– August 2013 (“Bystander Apathy – We ALL have a

role in prevention”)

• Action Plan– Outpatient– Inpatient

Page 22: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

22

Action PlanFentanyl Patch Disposal

• Outpatient Baylor Health Enterprises Pharmacies– Pharmacists Utilizing standardized teaching tool

emphasizing disposal• Tool can be found: www.ismp.org/AHRQ/default.asp

• Inpatient Care– Nursing Education for Fentanyl, Fold, and Flush– Consistent message across continuum of care

Page 23: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

23

http://www.fda.gov/downloads/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/EnsuringSafeUseofMedicine/SafeDisposalofMedicines/UCM337803.pdf

Page 24: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

24

Haloperidol Use

• Society of Critical Care Medicine– Revised Guidelines Published January 2013– Prior to update, the use of haloperidol for the

treatment of delirium was in the guidelines (Level C Recommendation)

– “There is no published evidence that treatment with haloperidol reduces the duration of delirium in adult ICU patients”

Page 25: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

25

Haloperidol Use

• Action Items:– Removed from Enterprise ICU Delirium Order

Sets.– Recommended that patients receiving via the

intravenous route of administration considered for telemetry monitoring.

Page 26: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

26

Zolpidem

• Journal of Hospital Medicine 2013;8:1-6 “Zolpidem is Independently Associated with Increased Risk of Inpatient Falls” – Published January 2013.

• FDA Drug Safety Communication – January 2013

– FDA Requires lower recommended doses…

Page 27: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

27

Zolpidem

• Action Plan:– Electronic Health Record Changes

• Revise order sets to remove pre-selection of prn insomnia medication.

• Dose revision to remove 10 mg ordering option– Only 5 mg on order sets– Removal of 10 mg order sentence for quick ordering

Page 28: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

28

Page 29: Jason Trahan,  Pharm.D . Director of Pharmacy – Medication Safety,  Baylor Scott & White

AHRQ eLearning Lesson on Preventing ADE “Preventing ADE: Individualizing Glycemic Targets Using Health Literacy”

An interactive eLearning course offered by the Office of Disease Prevention and Health Promotion, teaches providers how to:

• Apply health literacy strategies to provide personalized care for patients with diabetes, and to help them understand and act on information to prevent hypoglycemia

• Apply current, evidence-based guidelines for individualizing glycemic target goals

• Adopt the teach back method and shared decision-making in the health care setting

Continuing education (CME, CNE, CEU and CPE) is available

Visit http://health.gov/hai/training.asp#preventing_ades to participate


Top Related